REGENERATIVE RES FOUNDATION has a total of 23 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are HEMA QUEBEC, INNOVIR LAB INC and ROCKET PHARMACEUTICALS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | Canada | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Japan | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Stern Jeffrey | 17 |
#2 | Temple Sally | 12 |
#3 | Stern Sally Temple | 8 |
#4 | Salero-Coca Enrique L | 5 |
#5 | Messer Anne | 4 |
#6 | Lowry Natalia | 4 |
#7 | Goderie Susan K | 4 |
#8 | Butler David | 4 |
#9 | Jeffrey Stern | 2 |
#10 | Banerjee Akhilesh | 2 |
Publication | Filing date | Title |
---|---|---|
CA3036264A1 | Bi-functional anti-tau polypeptides and use thereof | |
US2015148383A1 | Methods for Inhibiting or Reversing Epiretinal Membrane Formation | |
CA2868785A1 | Compositions and methods for inhibiting drusen | |
WO2012003479A2 | Methods for culturing undifferentiated cells using sustained release compositions | |
EP2279247A1 | Retinal pigment epithelial stem cells | |
US2010021422A1 | Methods and compositions for delivery of exogenous factors to nervous system sites |